IssuerAnnouncementDetailsV2Portlet
Actions
Dallah Healthcare Co. Announces Its Intention to Purchase its Shares
| Element List | Explanation |
|---|---|
| Introduction | Dallah healthcare company announces the board of director’s resolution (by circulation) to buy up to 3,826,189 shares, equivalent to 3.917% of the company's ordinary shares and keeping the shares as treasury stocks. |
| Board Approval's Date | 2023-09-19 Corresponding to 1445-03-04 |
| Purpose of Purchase | To retain them as treasury shares. |
| Purpose of Purchase (If the Purpose to Keep the Shares as Treasury Shares) | To cover future swaps, if any, for the acquisition of a company shares or stakes or an asset purchase. |
| Number of Shares to be Bought | 3826189 |
| Shares Class and type | Ordinary shares |
| Method of Financing the Purchasing Process | The Company’s own resources |
| Current Percentage of the Treasury Shares at the Company out of the Total Class of Shares Purchased | 0 |
| Approvals and Meeting the Conditions of Financial Appropriateness | - The approval of the Extraordinary General Assembly (EGA) shall be obtained in the next EGA meeting for the shares purchase as per the requirements of sub-article (4) of Article (17) of the Implementing Regulations of the Company Law for Listed Joint Stock Companies. - The Company will also stick to the conditions of solvency requirements as set out in sub-article (3) of article (17) of the Implementing Regulations based on a Solvency Report that will be issued by the Company’s external auditors, which will be attached along with the EGM invitation that will approve this transaction as per regulation. |
| Voting Right | Purchased shares shall not have voting rights in the General Assembly’s Meetings. |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
Key Parameters
Last Price 130.6
Net Change 1.6 (+1.24%)
Value Traded (Sar) 17,388,006.5
Volume Traded 132,486
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions